ABCL Stock Summary and Trading Ideas (Abcellera Biologics - Common Shares | NASDAQ:ABCL)

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Abcellera Biologics - Common Shares trades on the NASDAQ stock market under the symbol ABCL.

As of April 25, 2024, ABCL stock price declined to $3.62 with 1,268,185 million shares trading.

ABCL has a beta of 2.18, meaning it tends to be more sensitive to market movements. ABCL has a correlation of 0.23 to the broad based SPY ETF.

ABCL has a market cap of $1.06 billion. This is considered a Small Cap stock.

Last quarter Abcellera Biologics - Common Shares reported $9 million in Revenue and -$.16 earnings per share. This beat revenue expectation by $299,000 and missed earnings estimates by -$.03.

In the last 3 years, ABCL stock traded as high as $36.05 and as low as $3.62.

The top ETF exchange traded funds that ABCL belongs to (by Net Assets): IBB, IDNA, SPDW, GWX, KOMP.

ABCL has underperformed the market in the last year with a price return of -49.5% while the SPY ETF gained +23.2%. ABCL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -31.2% and -18.8%, respectively, while the SPY returned +3.6% and -2.5%, respectively.

ABCL support price is $3.75 and resistance is $4.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABCL stock will trade within this expected range on the day.